Article Details
Retrieved on: 2021-03-24 12:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... planned to begin in Q4 2021, will evaluate clinical safety and efficacy of Aditxt's new approach to reprogramming and retraining the immune system.
Article found on: www.prnewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here